Representative April McClain Delaney (D-Maryland) recently sold shares of Revvity, Inc. (NYSE:RVTY). In a filing disclosed on March 20th, the Representative disclosed that they had sold between $15,001 and $50,000 in Revvity stock on February 28th.
Representative April McClain Delaney also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Laboratory Co. of America (NYSE:LH) on 2/28/2025.
- Purchased $15,001 – $50,000 in shares of Corpay (NYSE:CPAY) on 2/28/2025.
- Sold $1,001 – $15,000 in shares of Tempur Sealy International (NYSE:TPX) on 2/28/2025.
- Purchased $1,001 – $15,000 in shares of CACI International (NYSE:CACI) on 2/27/2025.
- Purchased $1,001 – $15,000 in shares of Laboratory Co. of America (NYSE:LH) on 2/27/2025.
- Purchased $1,001 – $15,000 in shares of Paychex (NASDAQ:PAYX) on 2/27/2025.
- Sold $15,001 – $50,000 in shares of Teledyne Technologies (NYSE:TDY) on 2/22/2025.
- Purchased $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 2/22/2025.
- Sold $1,001 – $15,000 in shares of Tempur Sealy International (NYSE:TPX) on 2/22/2025.
- Sold $1,001 – $15,000 in shares of CACI International (NYSE:CACI) on 2/22/2025.
Revvity Stock Up 0.2 %
NYSE:RVTY opened at $107.18 on Friday. The stock’s fifty day moving average price is $116.44 and its two-hundred day moving average price is $117.54. Revvity, Inc. has a 52-week low of $97.32 and a 52-week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The company has a market cap of $12.88 billion, a price-to-earnings ratio of 48.50, a P/E/G ratio of 3.82 and a beta of 1.06.
Revvity Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s dividend payout ratio is 12.67%.
Analyst Ratings Changes
Several research analysts have issued reports on the company. Barclays upped their price objective on Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price target on the stock in a research note on Friday, December 13th. KeyCorp increased their price target on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Sanford C. Bernstein downgraded Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target on the stock. in a research note on Friday, January 10th. Finally, Raymond James reissued an “outperform” rating and issued a $145.00 price target (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $136.25.
Read Our Latest Stock Analysis on Revvity
Insiders Place Their Bets
In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the transaction, the insider now owns 19,652 shares of the company’s stock, valued at approximately $2,295,550.12. This trade represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.
Institutional Trading of Revvity
Hedge funds have recently added to or reduced their stakes in the business. Wealth Enhancement Advisory Services LLC increased its holdings in Revvity by 20.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,952 shares of the company’s stock worth $553,000 after purchasing an additional 838 shares in the last quarter. Dogwood Wealth Management LLC increased its holdings in Revvity by 16.8% during the 4th quarter. Dogwood Wealth Management LLC now owns 4,987 shares of the company’s stock worth $557,000 after purchasing an additional 717 shares in the last quarter. Siemens Fonds Invest GmbH increased its holdings in Revvity by 264.8% during the 4th quarter. Siemens Fonds Invest GmbH now owns 13,357 shares of the company’s stock worth $1,491,000 after purchasing an additional 9,696 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Revvity during the 4th quarter worth about $16,293,000. Finally, Vermillion Wealth Management Inc. bought a new position in Revvity during the 4th quarter worth about $41,000. Institutional investors and hedge funds own 86.65% of the company’s stock.
About Representative McClain Delaney
April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.
April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.
About Revvity
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Featured Stories
- Five stocks we like better than Revvity
- Dividend Payout Ratio Calculator
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.